KAMADA » INVESTORS » NEWS & EVENTS

NEWS & EVENTS

Latest News

Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

Jul. 10, 2018

Kamada announced that it has received positive scientific advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the development plan for its proposed pivotal Phase 3 study for its proprietary Inhaled Alpha-1 Antitrypsin therapy (Inhaled AAT) for the treatment of alpha-1 antitrypsin deficiency (AATD).

50 years since the first use of Anti-D immunoglobulin

Jul. 1, 2018

Since 1967, the lives of countless babies have been saved by the pioneering Rh Program - and to date, millions of doses of anti-D have been given to Rh negative women.


Upcoming Events

Kamada to participate in 78th Scientific Sessions ADA

Jun. 22-26, 2018 / Orlando, Florida

The Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Over the course of five days, attendees will receive exclusive access to more than 2,800 original research presentations, take part in provocative and engaging exchanges with leading diabetes experts, and expand professional networks with nearly 13,000 professional attendees from around the world.


Past Event

Kamada to participate in 2018 BIO International Convention

Jun. 4-7, 2018 / Boston, Massachusetts

The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. 

The key benefits of attending the 2018 BIO International Convention are access to global biotech and pharma leaders via BIO One-on-One Partnering, exposure to industry though-leaders with over 500 education sessions at your fingertips, and unparalleled networking opportunities with 16,000+ attendees from 74 countries.